Search results
Author(s):
Gaetano Antonio Lanza
,
Hiroaki Shimokawa
Added:
11 months ago
ESC 23: LODESTAR Trial
Author(s):
Myeong-Ki Hong
Added:
7 months ago
Video
The Changing Face of Lipid Management in the UK
Video Series
Author(s):
Krishna Prasad
Added:
3 years ago
The field of cardiology has seen an unprecedented level of development in recent years both in terms of new therapeutic agents and devices. The field of cardiovascular therapeutics is fast approaching the state of an 'all inclusive area' with the overlap of areas such as diabetes and lipids.
With advent of the recent changes to European pharmaceutical regulations, including the clinical trial…
View more
Author(s):
Morihiro Matsuda
,
Kanako Yuasa
,
Toshiharu Kawamoto
,
et al
Added:
3 years ago
Topic: 5. Secondary Prevention of Cardiovascular Disease.
Introduction and Objectives
Liaison critical pathways (LCPs) for coronary artery disease (CAD) were developed to support collaborative care for CAD patients between cardiologists in emergency hospitals and referring physicians through sharing of medical information, including cardio protective medications and cardiovascular risk…
View more
Author(s):
J Christoph Geller
Added:
3 years ago
Cardiovascular disease is the leading cause of death worldwide. Elevated low-density lipoprotein (LDL) cholesterol levels, hypertension, diabetes and smoking are key modifiable risk factors.1,2 Published practice guidelines3–10 recommend aggressive treatment of individual risk factors and have defined thresholds for the initiation of and goals for treatment (see Table 1). These treatment…
View more
Author(s):
Ramón Arroyo-Espliguero
,
María Carmen Viana-Llamas
,
Alberto Silva-Obregón
,
et al
Added:
2 years ago
Inclisiran: A Jab Goes a Long Way
Author(s):
Krzysztof Filipiak
,
Bernard Man Yung Cheung
,
Alberto Lorenzatti
,
et al
Start date:
Jun 01, 2022
Broadcast
Author(s):
Martha Gulati
Added:
1 year ago
ESC Congress 2022 — In this short and practice-focused review, Dr Martha Gulati, Associate Director of the Barbra Streisand Women Heart Center and Director of CVD Prevention(Cedars-Sinai Medical Center, US) shares some her thoughts on the top 3 hot line trials.
Trials covered in detail include:
00:27: TIME:The Treatment in Morning versus Evening
01:57: SECURE:A polypill strategy in secondary…
View more
Author(s):
Philip A Poole-Wilson
Added:
3 years ago
Angina pectoris is a symptom that is usually, in the developed world, caused by obstruction to the coronary arteries by the enlargement of atheromatous lesions; there are other causes. The symptom can limit lifestyle, but more importantly is a repetitive reminder to the patient of the presence of heart disease, causing continual anxiety because of the belief that angina is the portent of early…
View more